X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Insights

Europe LIMS Market Steered By Germany – Arizton Report

Content Team by Content Team
13th April 2024
in Insights

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

As per a report by Arizton, the European laboratory information management system- LIMS market share is all set to reach $912.47 million by 2028.

It is well to be noted that the market happens to be growing at a CAGR of 10.16% between 2022 and 2028, research has found.

Elements that are shaping the market

With pharmaceutical as well as biotechnological industries making pretty high R&D investments, the report went on to state that the data generated needs apt processing and interpretation, hence decreasing the human errors provided by LIMS software solutions, therefore increasing the demand.

Increased challenges when it comes to data integrity, validity, and security are also contributing elements when it comes to the expansion of the European LIMS market, the report found out.

Moreover, partnerships and collaborations go on to promise huge demand as well as massive growth opportunities for even small and medium-sized firms in order to enter the market.

Regional status: LIMS market

Germany, as a matter of fact, happens to be the largest revenue contributor when it comes to Europe’s LIMS market, the data says.

For instance, Germany has gone on to occupy a market share of 21%, as it is regarded as the most research-intensive economy after the US and China. France holds the second largest market within the European countries, which happens to be followed by the UK and Italy, the authors stated.

In contrast, the report revealed that the United States is the largest revenue contributor to the global market. Based on the research, the US LIMS segment is anticipated to value $1 billion by 2028.

The effect of technological innovation

Demand when it comes to lab automation also happens to be driving the growth of the European LIMS market. This is thereby leading to the adoption when it comes to cloud-based lab automation solutions are concerned, added the report.

Especially, the report cited that LIMS offers value when it comes to terms of flexibility and value-added modules, in case the systems happen to be suitable for research and development labs, stability labs, as well as environmental monitoring labs.

The real-time collaboration among researchers and scientists, as well as the increasing requirement for remote access to laboratory data, have all resulted in a growth that’s exponential, to say the least, when it comes to the LIMS market.

Prominent players in the market happen to be Thermofisher Scientific, Labware, Labvantage, Labguru, Starlims, and Qbench.

Previous Post

Laboratory Information Management System - The 2024 Path

Next Post

Consistent Growth - Global Lab Information Systems Sector

Related Posts

wearable drug delivery devices
Insights

Wearable Drug Delivery Devices for On-Demand Care

27th September 2025
high volume injectable formulations
Insights

Overcoming Challenges in High-Volume Injectable Formulations

27th September 2025
Insights

Smart Drug Delivery Systems for Patient Care

27th September 2025
Insights

Green Chemistry in Sustainable API Manufacturing

26th September 2025
active pharmaceutical ingredients supply chain
Drug Development

Future of Active Pharmaceutical Ingredients Supply

26th September 2025
pharmaceutical excipients for new therapies
Drug Development

Advances in Pharmaceutical Excipients for New Therapies

26th September 2025
Next Post
Sorrento Receives US FDA Clearance to Proceed With Phase 1 Clinical Trial of STI-1499 Neutralizing Antibody in COVID-19 Positive Patients

Consistent Growth - Global Lab Information Systems Sector

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In